PRDX6 and neoplasm: We investigated whether NRF2 or peroxiredoxin 6 expression could predict clinical characteristics such as tumor status, lymph node status, or recurrence type (Fig. 2)Among all these analyses, no significant correlation was found between NRF2 or peroxiredoxin 6 expression and either tumor status or recurrence type.